Zhuochuming for diabetic swelling in the macula
Part of Eyes & vision clinical trials.
This study tests whether Zhuochuming®-3T&E, a new eye medicine, can reduce swelling in the macula (the center of the retina responsible for sharp vision) in people with diabetes who have never been treated for this condition before. The goal is to improve vision and prevent further vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and have never received treatment for macular swelling in the study eye
- Your vision in the study eye is between 20/32 and 20/320 (measured by an eye chart)
- Your eye's prescription is between -6.00 and +6.00 diopters (mild to moderate prescription range)
- You have not had eye surgery, laser treatment, steroid injections, or anti-VEGF injections in the study eye
- Your blood pressure and blood sugar are reasonably well controlled, and your other eye has at least 20/400 vision
- You are willing to attend regular eye exams and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called CU06-1004 for people with diabetic macular edema (swelling in the center of the retina caused by diabetes). It aims to see if the drug can improve vision and reduce swelling.
This study tests whether one eye injection (aflibercept) works better than another (bevacizumab) for people with diabetic macular edema. Both are already used for this condition, and the goal is to see which provides better vision improvement.
This trial tests whether a substance called tauroursodeoxycholate (TUDCA) or a traditional Chinese medicine can help reduce swelling in the back of the eye caused by diabetes. It is for people with diabetic retinopathy and diabetic macular edema who have not had recent eye surgeries or changes in blood sugar or blood pressure control.
This study compares a new medication, tabirafusp tedromer, to an existing treatment, aflibercept, for people with diabetic macular edema (swelling in the back of the eye from diabetes). It may help if your DME hasn't improved or you're looking for a new option.
This trial tests a high-dose version of the drug aflibercept (given as an eye injection) for people with diabetic macular edema who have previously had a vitrectomy surgery. The goal is to see if this higher dose can help reduce swelling and improve vision.
This trial tests a new eye drop or injection called ENN0403 for people with diabetic macular edema (swelling in the back of the eye due to diabetes). The goal is to see if it can improve vision and reduce swelling.
Hear when a new Diabetic Macular Edema (DME) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.